Nir Nimrodi

Mr. Nir Nimrodi has served as Special Advisor to the Evogene board since 2020.

Mr. Nimrodi brings 25 years of diverse international experience in both start-ups and large global businesses in the life science, pharmaceutical, and biotechnology industries.

Mr. Nimrodi is the Chairman and CEO of Accellix Inc since June 2019. Accellix aims to set a new standard in QC of Cell and Gene Therapies.

Prior to joining Accellix, Mr. Nimrodi served as the Chief Business Officer of Intrexon Corporation, a leader in synthetic biology. At Intrexon, Mr. Nimrodi held direct responsibility for all of the commercial stage enterprises. Mr. Nimrodi has led the transformation of Intrexon from an R&D organization to one with multiple products in the market, each with the potential of generating hundreds of millions of dollars annually.

Prior to Intrexon, Mr. Nimrodi has held positions with Life Technologies, Proneuron Biotechnologies, Mindsense Biosystems and Teva Pharmaceuticals.

Mr. Nimrodi holds a BA in Economics and an MBA from the Tel Aviv University.